Investor relations
Nordhealth is a company listed on Euronext Growth as NORDH
Investor presentations
A brief overview of the company and recent history.
- Watch Q3/2024 investor presentation Download Q3/2024 investor presentationNov 12, 2024
- Watch Q2/2024 investor presentation Download Q2/2024 investor presentationAugust 20, 2024
- Watch Q1/2024 investor presentation Download Q1/2024 investor presentationMay 14, 2024
- Watch Q4/2023 investor presentation Download Q4/2023 investor presentationMarch 5, 2024
Past presentations
- Watch Q3/2023 CMD presentation Download Q3/2023 CMD presentationNovember 14, 2023
- Watch Q3/2023 investor presentation Download Q3/2023 investor presentationNovember 14, 2023
- Watch Q2/2023 investor presentation Download Q2/2023 investor presentationAugust 22, 2023
- Watch Q1/2023 investor presentation Download Q1/2023 investor presentationMay 16, 2023
- Watch Q4/2022 investor presentation Download Q4/2022 investor presentationMarch 7, 2022
- Watch Q3/2022 investor presentation Download Q3/2022 investor presentationNovember 25, 2022
- Watch Q2/2022 investor presentation Download Q2/2022 investor presentationAugust 16, 2022
- Watch Q1/2022 investor presentation Download Q1/2022 investor presentationMay 20, 2022
- Watch Q4/2021 investor presentation Download Q4/2021 investor presentationMarch 8, 2022
- Watch EasyPractice acquisition investor presentationFebruary 2, 2022
- Watch Q3/2021 investor presentation Download Q3/2021 investor presentationNovember 30, 2021
- Watch H1/2021 investor presentation Download H1/2021 investor presentationSeptember 30, 2021
- Download Nordhealth introductionJune 3, 2021
Financial reports
- Download H1/2024 reportAugust 20, 2024
- Annual Financial Statements 2023April 12, 2024
- Download H2/2023 reportMarch 5, 2024
- Download H1/2023 reportAugust 22, 2023
- Annual Financial Statements 2022April 14, 2023
- Download H2/2022 reportMarch 7, 2023
- Download H1/2022 reportAugust 16, 2022
- Annual Financial Statements 2021April 29, 2021
- Download Q4/2021 reportMarch 8, 2021
- Download Q3/2021 reportNovember 30, 2021
- Download H1/2021 reportSeptember 30, 2021
Admission document
The attached information document has been prepared by Nordhealth solely for use in connection with the admission to trading of the Company’s class A shares on Euronext Growth Oslo, commencing on 3 June 2021.
Stock exchange releases
Get the latest stock exchange releases directly from our news platform.
- Nordhealth AS: Q3/2024 results presentationNovember 12, 2024
- Nordhealth AS - Invitation to Q3 2024 presentationNovember 5, 2024
- Nordhealth AS: Q2 and first half 2024 interim financial reportAugust 20, 2024
- Nordhealth AS - Invitation to Q2 2024 presentationAugust 13, 2024
- Nordhealth Announces Appointment of Karan Wallia as CEO of Therapy business unitJuly 30, 2024
- Annual General Meeting in Nordhealth ASMay 30, 2024
- Notice of Annual General Meeting of Nordhealth ASMay 16, 2024
- Nordhealth AS: Q1/2024 results presentationMay 14, 2024
- Nordhealth AS - Invitation to Q1 2024 presentationMay 6, 2024
- Nordhealth AS - Annual Financial Statements for 2023April 12, 2024